Novel Antimicrobial Treatment Strategy Based on Drug Delivery Systems for Acute Otitis Media

Area of Science:

• Otolaryngology
• Infectious Diseases
• Biomedical Engineering

Background:

• Acute otitis media (AOM) remains a significant medical concern despite existing vaccines and amoxicillin treatments.
• Challenges in AOM treatment include poor antibiotic penetration to the middle ear and the tympanic membrane acting as a barrier.
• Systemic side effects are a concern with conventional antimicrobial therapies.

Purpose of the Study:

• To review novel antimicrobial treatment strategies for AOM utilizing drug delivery systems (DDS).
• To explore how innovative DDS can enhance drug concentration in the middle ear for effective pathogen eradication.
• To discuss DDS approaches that bypass physical barriers and minimize systemic toxicity.

Main Methods:

• Review of literature on drug delivery systems (DDS) for AOM treatment.
• Discussion of sustained-release DDS to maintain therapeutic antibiotic concentrations.
• Exploration of trans-tympanic membrane DDS, including hydrogels with chemical permeation enhancers (CPEs).
• Consideration of bacteriophage-based DDS therapies.

Main Results:

• Sustained-release DDS can achieve and maintain minimum inhibitory concentrations (MIC) for time-dependent and dose-dependent antibiotics.
• Trans-tympanic DDS, like hydrogels with CPEs, show potential for enhanced drug delivery across the tympanic membrane.
• Bacteriophage-based DDS present a promising avenue for targeted antimicrobial action.

Conclusions:

• Innovative DDS offer a promising strategy for effective AOM antimicrobial treatment.
• DDS can overcome challenges related to drug penetration and systemic side effects.
• Single-dose DDS formulations represent an attractive future therapeutic approach for AOM.